A combination of interleukin-2 and 60 nm cationic supramolecular biovectors for the treatment of established tumours by subcutaneous or intranasal administration
| Autor: | El mir, S., Casanova, A., Betbeder, D., Triebel, F. * |
|---|---|
| Zdroj: | In European Journal of Cancer May 2001 37(8):1053-1060 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect